ot-interventional health care project RA-Express” to implement an efficient screening system for early arthritis

• Conditions: L93; L95; M05; M06; M07; M08; M13; M32; M35; M45

• Registration Number: DRKS00011510
• Lead Sponsor: Charité - Universitätsmedizin Berlin Klinik mit Schwerpunkt Rheumatologie und klinische Immunologie

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2016-07-31
• Study Start: 2017-03-02
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 177

Inclusion Criteria

Prescreening (by phone, online, consultation hours without appointment)
•Disease duration from four weeks to maximum 12 months
•At least one tender and swollen joint for more than four weeks
•No trauma or infection as cause of disorder
•No rheumatic diagnostic by other physician (e.g. family doctor, orthopaedist)
Requirement for the evaluation of the screened patients:
Signed agreement to scientific data collection, data storage and data evaluation.

Exclusion Criteria

None

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The aim of this study is to evaluate efficiency of different screening strategies in patients with early arthritis

Secondary Outcome Measures

Name	Time	Method
Secondary endpoints<br>•frequency of other inflammatory rheumatic diseases with involvement of joint symptoms<br>•number of screened patients diagnosed by physician<br>•number of screened patients diagnosed by health professional assistance using structured screening path<br>•number of patients using<br>a) online questionnaire on our website<br>b) appointment after questioning by phone<br>c) consultation hour without appointment<br>•evaluation of the accuracy of the diagnosis with and without using POCT rheumachec®/ MCV-test kits and CRP-test kits<br>•comparison between supposed diagnosis and final diagnosis<br>•collecting duration between first contact and<br>a) supposed diagnosis<br>b) final diagnosis<br>c) therapy start<br>•collecting duration between first<br>a) supposed diagnosis<br>b) final diagnosis<br>c) therapy start <br>with and without using POCT rheumachec®/ MCV-test kits and CRP-test kits<br>•evaluation of process costs<br>